Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep

Somatic in utero gene therapy aims to treat congenital diseases where pathology develops in perinatal life, thereby preventing permanent damage. The aim of this study was to determine whether delivery of self-complementary (sc) adeno-associated virus (AAV) vector in utero would provide therapeutic l...

Full description

Saved in:
Bibliographic Details
Main Author: Abi Nader, Khalil (author)
Other Authors: David, Anna L. (author), McIntosh, Jenny (author), Peebles, Donald (author), Cook, Terry (author), Waddington, Simon (author), Weisz, Boaz (author)
Format: article
Published: 2011
Online Access:http://hdl.handle.net/10725/3970
http://dx.doi.org/10.1089/hum.2010.007.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://online.liebertpub.com/doi/abs/10.1089/hum.2010.007
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513462547251200
author Abi Nader, Khalil
author2 David, Anna L.
McIntosh, Jenny
Peebles, Donald
Cook, Terry
Waddington, Simon
Weisz, Boaz
author2_role author
author
author
author
author
author
author_facet Abi Nader, Khalil
David, Anna L.
McIntosh, Jenny
Peebles, Donald
Cook, Terry
Waddington, Simon
Weisz, Boaz
author_role author
dc.creator.none.fl_str_mv Abi Nader, Khalil
David, Anna L.
McIntosh, Jenny
Peebles, Donald
Cook, Terry
Waddington, Simon
Weisz, Boaz
dc.date.none.fl_str_mv 2011
2016-06-07T11:00:45Z
2016-06-07T11:00:45Z
2016-06-07
dc.identifier.none.fl_str_mv 1043-0342
http://hdl.handle.net/10725/3970
http://dx.doi.org/10.1089/hum.2010.007.
David, A. L., McIntosh, J., Peebles, D. M., Cook, T., Waddington, S., Weisz, B., ... & Nathwani, A. C. (2010). Recombinant adeno-associated virus-mediated in utero gene transfer gives therapeutic transgene expression in the sheep. Human gene therapy, 22(4), 419-426.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://online.liebertpub.com/doi/abs/10.1089/hum.2010.007
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Human Gene Therapy
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Somatic in utero gene therapy aims to treat congenital diseases where pathology develops in perinatal life, thereby preventing permanent damage. The aim of this study was to determine whether delivery of self-complementary (sc) adeno-associated virus (AAV) vector in utero would provide therapeutic long-term transgene expression in a large animal model. We performed ultrasound-guided intraperitoneal injection of scAAV2/8-LP1-human Factor IX (hFIX)co (1 × 1012 vector genomes/kg) in early (n = 4) or late (n = 2) gestation fetal sheep. The highest mean hFIX levels were detected 3 weeks after injection in late gestation (2,055 and 1,687.5 ng/ml, n = 2) and 3 days after injection in early gestation (435 ng/ml, n = 1). Plasma hFIX levels then dropped as fetal liver and lamb weights increased, although low levels were detected 6 months after late gestation injection (75 and 52.5 ng/ml, n = 2). The highest vector levels were detected in the fetal liver and other peritoneal organs; no vector was present in fetal gonads. hFIX mRNA was detectable only in hepatic tissues after early and late gestation injection. Liver function tests and bile acid levels were normal up to a year postnatal; there was no evidence of liver pathology. No functional antibodies to hFIX protein or AAV vector were detectable, although lambs mounted an antibody response after injection of hFIX protein and Freund's adjuvant. In conclusion, hFIX expression is detectable up to 6 months after delivery of scAAV vector to the fetal sheep using a clinically applicable method. This is the first study to show therapeutic long-term hFIX transgene expression after in utero gene transfer in a large animal model.
eu_rights_str_mv openAccess
format article
id LAURepo_5a0ff64c697157ba57f4f03eda1d70db
identifier_str_mv 1043-0342
David, A. L., McIntosh, J., Peebles, D. M., Cook, T., Waddington, S., Weisz, B., ... & Nathwani, A. C. (2010). Recombinant adeno-associated virus-mediated in utero gene transfer gives therapeutic transgene expression in the sheep. Human gene therapy, 22(4), 419-426.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/3970
publishDate 2011
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the SheepAbi Nader, KhalilDavid, Anna L.McIntosh, JennyPeebles, DonaldCook, TerryWaddington, SimonWeisz, BoazSomatic in utero gene therapy aims to treat congenital diseases where pathology develops in perinatal life, thereby preventing permanent damage. The aim of this study was to determine whether delivery of self-complementary (sc) adeno-associated virus (AAV) vector in utero would provide therapeutic long-term transgene expression in a large animal model. We performed ultrasound-guided intraperitoneal injection of scAAV2/8-LP1-human Factor IX (hFIX)co (1 × 1012 vector genomes/kg) in early (n = 4) or late (n = 2) gestation fetal sheep. The highest mean hFIX levels were detected 3 weeks after injection in late gestation (2,055 and 1,687.5 ng/ml, n = 2) and 3 days after injection in early gestation (435 ng/ml, n = 1). Plasma hFIX levels then dropped as fetal liver and lamb weights increased, although low levels were detected 6 months after late gestation injection (75 and 52.5 ng/ml, n = 2). The highest vector levels were detected in the fetal liver and other peritoneal organs; no vector was present in fetal gonads. hFIX mRNA was detectable only in hepatic tissues after early and late gestation injection. Liver function tests and bile acid levels were normal up to a year postnatal; there was no evidence of liver pathology. No functional antibodies to hFIX protein or AAV vector were detectable, although lambs mounted an antibody response after injection of hFIX protein and Freund's adjuvant. In conclusion, hFIX expression is detectable up to 6 months after delivery of scAAV vector to the fetal sheep using a clinically applicable method. This is the first study to show therapeutic long-term hFIX transgene expression after in utero gene transfer in a large animal model.PublishedN/A2016-06-07T11:00:45Z2016-06-07T11:00:45Z20112016-06-07Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1043-0342http://hdl.handle.net/10725/3970http://dx.doi.org/10.1089/hum.2010.007.David, A. L., McIntosh, J., Peebles, D. M., Cook, T., Waddington, S., Weisz, B., ... & Nathwani, A. C. (2010). Recombinant adeno-associated virus-mediated in utero gene transfer gives therapeutic transgene expression in the sheep. Human gene therapy, 22(4), 419-426.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttp://online.liebertpub.com/doi/abs/10.1089/hum.2010.007enHuman Gene Therapyinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/39702021-03-19T10:03:20Z
spellingShingle Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep
Abi Nader, Khalil
status_str publishedVersion
title Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep
title_full Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep
title_fullStr Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep
title_full_unstemmed Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep
title_short Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep
title_sort Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep
url http://hdl.handle.net/10725/3970
http://dx.doi.org/10.1089/hum.2010.007.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://online.liebertpub.com/doi/abs/10.1089/hum.2010.007